SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.960
+0.100 (2.06%)
At close: Mar 20, 2026, 4:00 PM EDT
5.05
+0.09 (1.81%)
After-hours: Mar 20, 2026, 6:19 PM EDT
SOPHiA GENETICS Revenue
In the year 2025, SOPHiA GENETICS had annual revenue of $77.27M with 18.56% growth. SOPHiA GENETICS had revenue of $21.71M in the quarter ending December 31, 2025, with 22.41% growth.
Revenue (ttm)
$77.27M
Revenue Growth
+18.56%
P/S Ratio
4.40
Revenue / Employee
$186,195
Employees
415
Market Cap
339.69M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.27M | 12.10M | 18.56% |
| Dec 31, 2024 | 65.17M | 2.80M | 4.49% |
| Dec 31, 2023 | 62.37M | 14.81M | 31.14% |
| Dec 31, 2022 | 47.56M | 7.11M | 17.58% |
| Dec 31, 2021 | 40.45M | 12.05M | 42.43% |
| Dec 31, 2020 | 28.40M | 3.04M | 11.98% |
| Dec 31, 2019 | 25.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evolent Health | 1.88B |
| Claritev | 965.41M |
| TruBridge | 347.27M |
| HealthStream | 304.06M |
| Weave Communications | 239.02M |
| So-Young International | 201.13M |
| LifeMD | 194.06M |
| Spok Holdings | 139.71M |
SOPH News
- 17 days ago - SOPHiA GENETICS SA (SOPH) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - SOPHiA GENETICS Reports Fourth Quarter and Full Year 2025 Results - PRNewsWire
- 23 days ago - SOPHiA GENETICS to Present at the 46th Annual TD Cowen Health Care Conference - PRNewsWire
- 4 weeks ago - SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026 - PRNewsWire
- 5 weeks ago - SOPHiA GENETICS Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems - PRNewsWire
- 2 months ago - SOPHiA GENETICS Provides Preliminary Fourth Quarter and Full Year 2025 Financial Results, Initiates 2026 Guidance, and Announces Executive Transition Plan - PRNewsWire
- 2 months ago - SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology - PRNewsWire
- 4 months ago - SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine - PRNewsWire